Last updated 4 months ago

Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

121 patients around the world
Available in United States, Brazil, Spain
Telios Pharma, Inc.
2Research sites
121Patients around the world
This study is for people with
Myeloproliferative syndromes
Myelofibrosis
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital de Clínicas de Porto Alegre - HCPA/UFRGS
Recruiting
Rua Ramiro Barcelos, 2350, Av. Protásio Alves, 211 - Santa Cecília, Porto Alegre - RS, 90035-903
Instituto de Ensino e Pesquisa São Lucas
Recruiting
São Paulo, Sao Paulo, 01236-030
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy